louisakewell, Author at European Medical Journal - Page 46 of 153

Continue
18 Jan 2017

Juntendo University Research: Brain Imaging and Causal Assessment of Impairments Reveals Metamemory Regions

Tokyo, January 18, 2017 – Juntendo University researchers identify areas of the brain responsible for metacognitive memory evaluation in macaque monkeys.
17 Jan 2017

AMRA Announces $9 Million Investment from Pfizer Venture Investments, Novo Seeds and Industrifonden

Sweden, January 17, 2017 – Swedish-based digital health company AMRA has announced today a $9 million funding round co-led by US-based Pfizer Venture…
10 Jan 2017

Introducing EMJ Innovations 1.1

United Kingdom, January 10, 2017: Happy new year and welcome to our first journal of the year, the inaugural edition of the European Medical Journal…
15 Mins
10 Jan 2017

Review of MEDICA 2016

Welcome to European Medical Journal’s review of MEDICA 2016, the largest and most impactful medical trade fair globally…
6 Mins
10 Jan 2017

Revolutionising Healthcare by Empowering Patients to Innovate

A growing stream of literature argues for a more active role for patients and caregivers in healthcare delivery, namely in…
7 Mins
10 Jan 2017

New Models of Health

Last year in England alone there were approximately 57 million failed attempts to book general practitioner appointments.
19 Dec 2016

RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. In South Korea

Israel, December 14, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…
19 Dec 2016

Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement

USA and Germany, December 15, 2016 – bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene…
19 Dec 2016

First Data on Rare Sarcomas in Asian Patients Presented at ESMO Asia in Singapore

Lugano-Singapore, December 17, 2016 – The first data on rare sarcomas in Asian patients is presented in three studies today at the ESMO Asia 2016…
16 Dec 2016

RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn’s Disease

Israel, December 13, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…